In a move to strengthen workforce readiness, the Pharmaceutical Academy for Global Excellence (PAGE) has partnered with 8chili Inc. to roll out an AI and VR pharma manufacturing training platform in India. The initiative targets a critical skills...
The Merck & Google Cloud partnership is set to reshape how one of the world’s largest pharmaceutical companies operates, with a deal worth up to USD 1 billion aimed at turning Merck into a fully AI-enabled enterprise.
Scientists have uncovered a new clue about how anxiety disorders may develop in the brain, pointing to a surprising source — the brain’s own immune cells in the brain. A recent study conducted in mice suggests that calcium activity inside speciali...
A team at National Institute of Technology Rourkela has developed a new bio-ink for 3D bioprinting, offering fresh potential for pharmaceutical research and tissue engineering. The bio-ink for 3D bioprinting is engineered to improve both...
India’s pharmaceutical industry is well-equipped to deal with short-term supply disruptions, according to the Central Government, which says strong domestic production of key raw materials provides stability during global uncertainty.
India is steadily emerging as a global leader in using artificial intelligence in healthcare, thanks to its strong digital growth, increasing health awareness, and rising investments in health technology. As AI becomes a part of everyda...
Indian oncology medicine manufacturers are witnessing a clear disconnect between rapid scientific innovation — including targeted therapies, biosimilars, next-generation sequencing (NGS), minimal residual disease assays, and immuno-oncology treatm...
India is facing a growing public health concern as energy drinks are increasingly being linked to liver damage in young adults. Doctors across the country report a noticeable rise in patients in their 20s and 30s showing early signs of liver...
India may see a rise in medicine prices as the West Asia conflict drives up raw material and logistics costs, impacting pharma companies and raising concerns over supply and affordability.
The India pharma startups ecosystem is stepping into a defining decade. For years, it powered global healthcare as the “Pharmacy of the World,” supplying cost-effective generics at unmatched scale. But in 2026, that identity is no longer enough.
.jpg)
, CDSCO.jpg)